Browse studies, page 394
Page 394 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Determining the optimal dose of lansoprazole injection by 24-hour intragastric pH monitoring Journal of clinical gastroenterology, 1995
- Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole) Nihon rinsho. Japanese journal of clinical medicine, 2000
- Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997
- Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status Clinical pharmacology and therapeutics, 1997
- Effect of lansoprazole on peptic ulcers Journal of clinical gastroenterology, 1995
- 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection The American journal of gastroenterology, 1996
- Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function Journal of clinical gastroenterology, 1995
- Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer Orvosi hetilap, 2000
- Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection Helicobacter, 1998
- Effect of postoperative proton pump inhibitor therapy on voice outcomes following phonomicrosurgery for vocal fold polyp: a randomized controlled study Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2016
- The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study Alimentary pharmacology & therapeutics, 2005
- A trial of lansoprazole in refractory gastric ulcer Alimentary pharmacology & therapeutics, 1996
- Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection The Netherlands journal of medicine, 1998
- Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers Pharmacotherapy, 2006
- Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome Alimentary pharmacology & therapeutics, 1996
- Comparative recurrence rate investigation of esomeprazole versus lansoprazole in triple-combination therapy to eradicate Helicobacter pylori infection among pediatrics: multicentre, randomized, and controlled trials Intisari Sains Medis, 2024
- Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial Journal of Clinical Oncology, 2023
- Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection World Journal of Gastroenterology, 2007
- Repeatability of small bowel transit time in capsule endoscopy in healthy subjects Bio-medical materials and engineering, 2018
- Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): Rationale and methods Contemporary Clinical Trials, 2019
- Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori ACP Journal Club, 2008
- Lansoprazole for recurrent abdominal pain in adolescents 2011
- Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia American Journal of Gastroenterology, 2003
- Amitriptyline for the Treatment of Extra-esophageal Symptoms in Proton Pump Inhibitor-refractory Patients With Suspected Gastroesophageal Reflux Disease Journal of Neurogastroenterology and Motility, 2025
- Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial World Journal of Gastroenterology, 2005
- Effectivity of Esomeprazole Compared with Lansoprazole in the Treatment of Pediatric with Gastritis Open Access Macedonian Journal of Medical Sciences, 2021
- A Multicenter, Randomized, Comparative Study to Determine the Appropriate Dose of Lansoprazole for Use in the Diagnostic Test for Gastroesophageal Reflux Disease Gut and Liver, 2011
- Efficacy and safety of lansoprazole in patients with low-to-moderate bleeding risk undergoing percutaneous coronary intervention European Journal of Medical Research, 2026
- Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial World Journal of Gastroenterology, 2006
- Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial Digestion, 2011
- Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea Gut and Liver, 2019
- Lansoprazole in globus pharyngeus: double-blind, randomized, placebo-controlled trial The Journal of Otolaryngology, 2008
- Randomized Clinical Trial of Lansoprazole for Poorly Controlled Asthma in Children Journal of the American Medical Association (JAMA), 2012
- Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial Gastroenterology Research and Practice, 2015
- Ibuprofen - a Safe Analgesic During Cardiac Surgery Recovery? A Randomized Controlled Trial Journal of Cardiovascular and Thoracic Research, 2015
- Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial Journal of gastroenterology, 2011
- Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients American Journal of Gastroenterology, 2001
- Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial Journal of gastroenterology, 2012
- Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial Trials, 2017
- Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial Journal of Gastric Cancer, 2017
- Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial Canadian Journal of Gastroenterology and Hepatology, 2017
- Fourteen-day vonoprazan-amoxicillin dual therapy versus 14-day bismuth-based quadruple therapy for Helicobacter pylori treatment: a randomized clinical trial Therapeutic Advances in Gastroenterology, 2025
- A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers Clinical and Translational Gastroenterology, 2015
- Celecoxib Monotherapy Maintained Small Intestinal Mucosa Better Compared With Loxoprofen Plus Lansoprazole Treatment: A Double-blind, Randomized, Controlled Trial Journal of Clinical Gastroenterology, 2016
- Efficacy and safety of lansoprazole combined with flupentixol-melitracen for functional dyspepsia: A randomized, double-blinded, placebo-controlled clinical trial World Journal of Gastroenterology, 2026
- Vonoprazan Versus Lansoprazole in the Treatment of Artificial Gastric Ulcers After Endoscopic Submucosal Dissection: a Randomized Controlled Trial 2020
- Preoperative Lansoprazole With or Without Domperidone and Gastric Content Characteristics: A Randomized Placebo-Controlled Trial The Anatolian Journal of Anesthesiology and Intensive Care, 2026
- Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori Medicine, 2021
- Older adults' attitudes towards deprescribing and medication changes: a longitudinal sub-study of a cluster randomised controlled trial BMJ open, 2024
- Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial Helicobacter, 2019
- Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study Helicobacter, 2019
- Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial BMC gastroenterology, 2021
- Comparative Study of Two Semi-Occluded Vocal Tract Protocols: A Randomized Clinical Trial Journal of speech, language, and hearing research : JSLHR, 2024
- A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of ART-001 with a novel oral pediatric formulation in healthy subjects Clinical and translational science, 2023
- Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers Nagoya journal of medical science, 2023
- Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients Journal of clinical gastroenterology, 2020
- Comparative Effectiveness of Ascorbic Acid vs. Calcium Ascorbate Ingestion on Pharmacokinetic Profiles and Immune Biomarkers in Healthy Adults: A Preliminary Study Nutrients, 2024
- Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication in Chinese population: A prospective, multicenter, randomized, two-stage study World journal of gastroenterology, 2024
- Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma Medical oncology (Northwood, London, England), 2021
- Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer Breast (Edinburgh, Scotland), 2024
- Impact of proton pump inhibitors on cytochrome P450 activity assessed by 13 C-aminopyrine breath test in patients with cirrhosis Alimentary pharmacology & therapeutics, 2021
- A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study Journal of gastroenterology, 2022
- Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial World journal of gastroenterology, 2024
- The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study The Korean journal of internal medicine, 2022
- The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study Alimentary pharmacology & therapeutics, 2022
- Harm and Medication-Type Impact Agreement with Hypothetical Deprescribing Recommendations: a Vignette-Based Experiment with Older Adults Across Four Countries Journal of general internal medicine, 2023
- Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial Journal of gastroenterology and hepatology, 2022
- Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2022
- Electronic Decision Support for Deprescribing in Older Adults Living in Long-Term Care: A Stepped-Wedge Cluster Randomized Trial JAMA network open, 2025
- Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection Scientific reports, 2024
- Effect of pharmacist counseling on patient medication compliance and helicobacter pylori eradication among jordanian outpatients Arquivos de gastroenterologia, 2023
- Acid Suppression in Mild-Moderate Laryngomalacia Without GERD: A Randomized Controlled Trial The Laryngoscope, 2026
- Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial BMC gastroenterology, 2024
- Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial World journal of gastroenterology, 2025
- Effectiveness of a checklist for enteral medication administration: A randomized controlled trial Nursing in critical care, 2025
- Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis BMC gastroenterology, 2023
- Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2023
- Efficacy evaluation and exploratory analysis of influencing factors of Banxia Houpu Decoction in the treatment of refractory gastroesophageal reflux disease Medicine, 2024
- Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial Cancer prevention research (Philadelphia, Pa.), 2026
- A cost-effectiveness analysis of melatonin in comparison with midazolam for anxiety prior to general anaesthesia in children: the MAGIC randomised controlled trial (melatonin for anxiety prior to general anaesthesia in children) BMC anesthesiology, 2025
- Culture-based susceptibility-guided tailored versus empirical concomitant therapy as first-line Helicobacter pylori treatment: A randomized clinical trial United European gastroenterology journal, 2024
- Evaluation of the clinical pharmacist's effect on achieving treatment goals in patients with hypothyroidism: a randomized controlled trial BMC endocrine disorders, 2025
- Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial Pharmacogenomics, 2026
- Comparative Sensory Evaluation of Pediatric Liquid Omeprazole Formulations Available in the UK Clinical drug investigation, 2026
- Long-term health conditions and their impact on people with sleep disturbances and dementia BMC geriatrics, 2025
- Vonoprazan-based therapy versus standard regimen for Helicobacter pylori infection management in Egypt: an open-label randomized controlled trial Scientific reports, 2025
- Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial Helicobacter, 2026
- Evaluation of a pantoprazole and 4-desmethylpantoprazole-sulfate metabolic ratio as a novel CYP2C19 phenotyping method British journal of clinical pharmacology, 2026
- Eradication of Helicobacter pylori for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT Health technology assessment (Winchester, England), 2025
- LOW-nickel diet as a strategy in the treatment of helicobacter pylori infection Arquivos de gastroenterologia, 2025
- Evaluating the cost-effectiveness of replacing lansoprazole with vonoprazan for treating erosive oesophagitis BMJ open gastroenterology, 2025
- Assessment of Pharmacokinetic Interaction and Clinical Efficacy of Clopidogrel Co-administered with Ilaprazole Clinical pharmacology in drug development, 2026
- Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country Alimentary pharmacology & therapeutics, 1998
- Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2006
- Acid control with esomeprazole and lansoprazole: a comparative dose-response study Scandinavian journal of gastroenterology, 2007
- Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes Journal of clinical pharmacology, 2004
- Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells Digestive diseases and sciences, 1999
- Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin Alimentary pharmacology & therapeutics, 2002
- Management of symptoms in step-down therapy of gastroesophageal reflux disease Journal of gastroenterology and hepatology, 2005
- Lansoprazole potentiates vecuronium paralysis Journal of the Indian Medical Association, 1997
